🇺🇸 FDA
Pipeline program

modified BEAM

XJTU1AF2022LSL-018

Unknown small_molecule active

Quick answer

modified BEAM for Autologous Stem Cell Transplantation is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Autologous Stem Cell Transplantation
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials